A study to compare the outcome of joint lavage with i-PRF injection in treatment of TMJ disease using conventional method and/or using 3D printed patient model.
- Conditions
- Health Condition 1: M266- Temporomandibular joint disorders
- Registration Number
- CTRI/2022/09/045728
- Lead Sponsor
- Punjab Government Dental College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
1 Adult patients above 18 years of age.
2 Patient who did not respond to conservative treatment such as soft diet analgesics etc
3 Patient suffering from internal derangement of TMJ diagnosed with CT
of Wilke’s stage 1, 2, 3
4 Patient with unilateral pain, clicking sound or limited mouth
opening/closing.
1 Patients with any systemic or malignant disease.
2 Patients who had previous TMJ invasive surgeries such as arthrocentesis
arthroscopy maxillofacial trauma disc perforation.
3 Patients with Wilkes stage 4 5
4 Patients refused or to give consent for follow up.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Following Parameters are used to evaluate between conventional arthrocentesis and ARTHROCENTESIS using CT guided 3D printed patient specific guide. <br/ ><br> <br/ ><br>1 Operative period will be recorder with the timer commenced from the insertion of first needle to visualization of solution from second needle. <br/ ><br>2 Intra operative complications such as bleeding from ear. <br/ ><br> <br/ ><br> <br/ ><br>3 Post operative complications such as facial paralysis pain hematoma etc <br/ ><br> <br/ ><br>4 Pain will be assessed with Wisconsin Brief Pain Questionnare (1983) <br/ ><br> <br/ ><br>5 Maximal mouth opening recorded by measuring the distance between upper and lower incisors in midline in millimeter before the procedure and after consecutive follow ups <br/ ><br> <br/ ><br>Timepoint: Post operative assessments after the first intervention will be conducted at 3 days, 2 weeks followed by 1, 2, 3, 6 months
- Secondary Outcome Measures
Name Time Method not applicableTimepoint: not applicable